Skip to content

LBRX LBRX Operating Lease Liabilities

Operating Lease Liabilities at other companies

Alkermes logo
AlkermesALKS
$63.75M-6.0%
MapLight Therapeutics, Inc.
 logo
MapLight Therapeutics, Inc. MPLT
$4.67M
Alto Neuroscience logo
Alto NeuroscienceANRO
$3.56M-19.4%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$741K-36.0%
Opko Health logo
Opko HealthOPK
$35.64M-7.1%
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
$39M-12.6%

Other financials

Income statement

See full
Net income-$19.1M-259%
EPS (diluted)-$0.67+95.5%

Balance sheet

See full
Cash & equivalents$320.7M
Total debt$3.5M
Total equity$378.7M+481%
Total assets$393.5M

Cash flow

See full
Operating cash flow-$23.3M-187%
CapEx$32.0K+52.4%
Free cash flow-$23.3M-186%

Valuation

See full
Market cap$874.06M+159%
Enterprise value$556.86M

Returns & leverage

See full
Return on equity-27.9%
Debt / equity
Current ratio35.7×

Where this comes from

Reported directly by LBRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.

The official record: LBRX’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about LBRX's operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LBRX's operating lease liabilities?
LBRX (LBRX) reported operating lease liabilities of $2.74M in Q1 2026.
What does operating lease liabilities mean?
Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.